http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5248767-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fa84c54c24536575f7f12c1f1db43
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00
filingDate 1992-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cf25c6e5e239f1d1f039cb4eb7b706e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3547afe915926c7a7e6d7646147fdbc
publicationDate 1993-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5248767-A
titleOfInvention Process for the preparation of a pasteurized immunoglobulin preparation using ethanol
abstract A process for the production of a pasteurized immunoglobulin preparation is described, which comprises heating a solution of an immunoglobulin in the presence of a carboxylic acid or one of its salts and/or of a saccharide until viable pathogens, which may remain undetected in conventional tests, in particular hepatitis viruses or HTLV III ("Aids") viruses, are inactivated i.e. are rendered incapable of reproduction and/or of being intracellularly or otherwise reproduced. A preparation of this type can be used for therapy or prophylaxis or as component of a diagnostic kit.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11466051-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015086566-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-783155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5608038-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0174408-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2806910-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003180373-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6737405-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001051154-A1
priorityDate 1986-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4164495-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4721777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4579735-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0058993-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0177836-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0196761-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4762714-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4687664-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4640834-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3100737-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0139975-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700386

Total number of triples: 52.